Shire urges AbbVie to stick to original deal plan
October 15, 2014 at 02:55 AM EDT
LONDON (Reuters) - London-listed pharmaceutical firm Shire plc said it believed U.S. suitor AbbVie should proceed with its $55 billion takeover despite a change to U.S. regulations which curbed the tax benefits of the tie-up.